Commercial Int Bank - CIB Condensed Consolidated 3rd Quarter Results
RNS Number : 0124G Commercial Intnl Bank (Egypt) SAE 04 November 2025
| Condensed Consolidated Interim Statement of Financial Position as at September 30, 2025 Click on, or paste the following link into your web browser, to view the associated PDF document http://www.rns-pdf.londonstockexchange.com/rns/0124G_1-2025-11-3.pdf | |||||
| Notes | Sep. 30, 2025 | Dec. 31, 2024 | |||
| Assets | |||||
| Cash and balances at the central bank | 10 | 21,886,031 | 136,531,020 | ||
| Due from banks | 11 | 227,409,917 | 270,829,834 | ||
| Loans and advances to banks, net | 13 | 26,914,884 | 9,555,410 | ||
| Loans and advances to customers, net | 14 | 455,719,759 | 343,542,674 | ||
| Derivative financial instruments | 1,222,908 | 819,711 | |||
| Financial investments | |||||
| - Financial Assets at Fair Value through P&L | 15 | 2,203,869 | - | ||
| - Financial Assets at Fair Value through OCI | 15 | 331,039,059 | 234,512,167 | ||
| - Financial Assets at Amortized cost | 15 | 230,685,849 | 168,118,219 | ||
| Investments in associates | 16 | 44,485 | 98,193 | ||
| Other assets | 17 | 50,063,317 | 44,282,773 | ||
| Deferred tax assets | 2,855,007 | 2,685,331 | |||
| Property and equipment | 18 | 5,533,749 | 3,997,929 | ||
| Total assets | 1,355,578,834 | 1,214,973,261 | |||
| Liabilities and equity | |||||
| Liabilities | |||||
| Due to banks | 19 | 7,452,244 | 2,034,885 | ||
| Due to customers | 20 | 1,047,463,990 | 972,595,958 | ||
| Non-current liabilities held for sale | 1,362 | 1,397 | |||
| Derivative financial instruments | 223,670 | 100,571 | |||
| Current income tax liabilities | 15,857,818 | 18,327,968 | |||
| Other liabilities | 21 | 27,009,254 | 21,441,169 | ||
| Issued debt instruments | 22 | 4,779,461 | 5,067,781 | ||
| Other loans | 30,249,278 | 23,962,389 | |||
| Other provisions | 23 | 14,495,239 | 18,621,822 | ||
| Total liabilities | 1,147,532,316 | 1,062,153,940 | |||
| Equity | |||||
| Issued and paid capital | 30,708,510 | 30,431,580 | |||
| Reserves | 105,653,930 | 63,544,579 | |||
| Reserve for employee stock ownership plan (ESOP) | 2,071,247 | 1,868,235 | |||
| Retained earnings* | 69,374,741 | 56,791,883 | |||
| Total equity and net profit for the period / year | 207,808,428 | 152,636,277 | |||
| Non-Controlling Interest | 238,090 | 183,044 | |||
| Total NCI, equity and net profit for the period / year | 208,046,518 | 152,819,321 | |||
| Total liabilities and equity | 1,355,578,834 | 1,214,973,261 | |||
| The accompanying notes are an integral part of these financial statements. | |||||
| (Review report attached) | |||||
| * | Including net profit for the period | ||||
| Condensed Consolidated Interim Income Statement for the period ended September 30, 2025 | ||||||
| Last 9 Months | Last 9 Months | |||||
| Notes | Sep. 30, 2025 | Sep. 30, 2024 | ||||
| Interest and similar income | 158,400,209 | 130,999,623 | ||||
| Interest and similar expense | (79,746,672) | (65,316,717) | ||||
| Net interest income | 78,653,537 | 65,682,906 | ||||
| Fee and commission income | 11,609,232 | 9,274,284 | ||||
| Fee and commission expense | (5,227,210) | (4,049,111) | ||||
| Net fee and commission income | 6,382,022 | 5,225,173 | ||||
| Dividend income | 65,216 | 70,934 | ||||
| Net trading income | 6 | 1,282,250 | 18,194,491 | |||
| Profits (Losses) on financial investments | 15.1 | 694,076 | 377,992 | |||
| Administrative expenses | (12,432,780) | (9,180,646) | ||||
| Other operating income (expenses) | 7 | 668,432 | (17,995,808) | |||
| Impairment release (charges) for credit losses | 9 | 7,968,084 | (3,745,003) | |||
| Bank's share in the profits / losses of associates | 9,787 | (8,533) | ||||
| Profit before income tax | 83,290,624 | 58,621,506 | ||||
| Income tax expense | 29 | (21,842,182) | (17,207,903) | |||
| Deferred tax assets (Liabilities) | 29 | 651,822 | 934,295 | |||
| Net profit for the period | 62,100,264 | 42,347,898 | ||||
| Non-Controlling Interest | 569 | (45) | ||||
| Bank's shareholders | 62,099,695 | 42,347,943 | ||||
| Earnings per share | 8 | |||||
| Basic | 18.54 | 12.50 | ||||
| Diluted | 18.36 | 12.38 | ||||
| Condensed Consolidated Interim statement of Comprehensive Income for the period ended September 30, 2025 | ||||||
| Last 9 Months | Last 9 Months | |||||
| Sep. 30, 2025 | Sep. 30, 2024 | |||||
| Net profit for the period | 62,100,264 | 42,347,898 | ||||
| Transferred to RE from financial assets at fair value through OCI | (110,995) | (370,224) | ||||
| Net change on financial assets at fair value through comprehensive income after tax | 7,306,189 | 8,272,930 | ||||
| Cumulative foreign currencies translation differences | (274,766) | 883,684 | ||||
| Effect of ECL on debt instruments measured at fair value through OCI | (397,890) | 623,199 | ||||
| Total comprehensive income for the period | 68,622,802 | 51,757,487 | ||||
| As follows: | ||||||
| Bank's shareholders | 68,508,336 | 51,757,532 | ||||
| Non-Controlling Interest | 114,466 | (45) | ||||
| Total comprehensive income for the period | 68,622,802 | 51,757,487 | ||||
| Condensed Consolidated Interim Cash flows for the period ended September 30, 2025 | ||||||||||
| Notes | Sep. 30, 2025 | Sep. 30, 2024 | ||||||||
| Cash flow from operating activities | ||||||||||
| Profit before income tax | 83,290,624 | 58,621,506 | ||||||||
| Adjustments to reconcile profits to net cash provided by operating activities | ||||||||||
| Fixed assets depreciation | 18 | 1,680,325 | 763,079 | |||||||
| Impairment release/charge for credit losses (Loans and advances to customers and banks) | 9 | (7,969,627) | 4,224,251 | |||||||
| Net charged/released for other provisions | 23 | (4,072,083) | 430,005 | |||||||
| Impairment release/charge for credit losses (due from banks) | 9 | 147,709 | 829 | |||||||
| Impairment release/charge for credit losses (financial investments) | 9 | (146,166) | (480,077) | |||||||
| Impairment release/charge for other assets | 105 | (11,956) | ||||||||
| Exchange revaluation differences for financial assets at fair value through OCI and AC | 4,669,694 | (18,536,183) | ||||||||
| Revaluation differences impairment charge for Financial Assets at Fair value through OCI | (224,869) | 1,193,810 | ||||||||
| Revaluation differences impairment charge for Financial Assets at Amortized cost | (16,709) | 107,207 | ||||||||
| Revaluation differences impairment charge for due from banks | (7,894) | 1,308 | ||||||||
| Net utilized/recovered for other provisions | 23 | (2,039) | (9,196) | |||||||
| Exchange revaluation differences of other provisions | 23 | (52,461) | 3,962,591 | |||||||
| Profits/losses from selling property and equipment | (8,006) | (2,254) | ||||||||
| Profits/losses from selling financial investments at fair value through OCI | 15.1 | (416,668) | (377,992) | |||||||
| Profits/losses from selling investments in associates | 15.1 | (277,408) | - | |||||||
| Share based payments | 990,324 | 804,345 | ||||||||
| Bank's share in the profits / losses of associates | (9,787) | 8,533 | ||||||||
| Operating profits before changes in operating assets and liabilities | 77,575,064 | 50,699,806 | ||||||||
| Net decrease / increase in assets and liabilities | ||||||||||
| Due from banks | 159,740,470 | (14,547,420) | ||||||||
| Financial assets at fair value through P&L | (2,203,869) | (2,066,889) | ||||||||
| Derivative financial instruments | (306,569) | (225,875) | ||||||||
| Loans and advances to banks and customers | (121,599,501) | (75,774,541) | ||||||||
| Other assets | (2,747,423) | (14,094,581) | ||||||||
| Due to banks | 19 | 5,417,359 | (8,658,023) | |||||||
| Due to customers | 20 | 74,868,032 | 223,729,483 | |||||||
| Current income tax obligations paid | (5,984,364) | (2,938,397) | ||||||||
| Non-current liabilities held for sale | (35) | 1,327 | ||||||||
| Other liabilities | (12,910,605) | (5,488,554) | ||||||||
| Net cash generated from (used in) operating activities | 171,848,559 | 150,636,336 | ||||||||
| Cash flow from investing activities | ||||||||||
| Proceeds from sale of investments in associates | 339,920 | 11,956 | ||||||||
| Payments for purchases of property, equipment and branches construction | (6,216,697) | (2,401,070) | ||||||||
| Proceeds from selling property and equipment | 7 | 8,006 | 2,254 | |||||||
| Proceeds from redemption of financial assets at amortized cost | 21,382,288 | 1,226,638 | ||||||||
| Payments for purchases of financial assets at amortized cost | (84,177,641) | (106,105,142) | ||||||||
| Payments for purchases of financial assets at fair value through OCI | (191,735,116) | (22,138,419) | ||||||||
| Proceeds from selling financial assets at fair value through OCI | 98,091,318 | 55,475,567 | ||||||||
| Net cash generated from (used in) investing activities | (162,307,922) | (73,928,216) | ||||||||
| Condensed Consolidated Interim Cash flows for the period ended September 30, 2025 (Cont.) | ||||||||||
| Sep. 30, 2025 | Sep. 30, 2024 | |||||||||
| Cash flow from financing activities | ||||||||||
| Other loans | 6,286,889 | 7,840,786 | ||||||||
| Dividends | (14,773,854) | (5,116,159) | ||||||||
| Issued debt instruments | (288,320) | 1,738,393 | ||||||||
| Capital increase | 276,930 | 236,570 | ||||||||
| Net cash generated from (used in) financing activities | (8,498,355) | 4,699,590 | ||||||||
| Net (decrease) increase in cash and cash equivalent during the period | 1,042,282 | 81,407,710 | ||||||||
| Beginning balance of cash and cash equivalent | 226,610,721 | 234,317,913 | ||||||||
| Cash and cash equivalent at the end of the period | 227,653,003 | 315,725,623 | ||||||||
| Cash and cash equivalent comprise: | ||||||||||
| Cash and balances at the central bank | 10 | 21,886,031 | 94,568,773 | |||||||
| Due from banks | 227,553,557 | 305,240,021 | ||||||||
| Treasury bills and other governmental notes | 12 | 141,529,607 | 82,174,775 | |||||||
| Obligatory reserve balance with central bank | (2,865,828) | (76,360,420) | ||||||||
| Due from banks with maturity more than three months | (19,202,757) | (19,125,420) | ||||||||
| Treasury bills and other governmental notes with maturity more than three months | (141,247,607) | (70,772,106) | ||||||||
| Total cash and cash equivalent | 227,653,003 | 315,725,623 | ||||||||
| Condensed Consolidated Interim statement of changes in shareholders' equity | |||||||||||||||||
| Sep. 30, 2024 | Issued and paid capital | Legal reserve | General reserve | General risk reserve | Special reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders' Equity | Non-Controlling Interest | Total | ||
| Beginning balance | 30,195,010 | 4,770,354 | 39,840,707 | 1,550,906 | - | (670,972) | 21,155 | (16,868,691) | 15,230 | 29,993,331 | 1,486,010 | 148,353 | 90,481,393 | 160,073 | 90,641,466 | ||
| Capital increase | 236,570 | - | - | - | - | - | - | - | - | - | - | - | 236,570 | - | 236,570 | ||
| Transferred to reserves | - | 1,438,320 | 22,582,085 | - | - | - | 1,663 | - | - | (23,398,943) | (623,125) | - | - | - | - | ||
| Net profit for the period | - | - | - | - | - | - | - | - | - | 42,347,943 | - | - | 42,347,943 | (45) | 42,347,898 | ||
| Dividends paid | - | - | - | - | - | - | - | - | - | (5,366,429) | - | - | (5,366,429) | (37,367) | (5,403,796) | ||
| Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | - | - | (370,224) | - | 370,224 | - | - | - | - | - | ||
| Net change on financial assets at fair value through OCI after tax | - | - | - | - | - | - | - | 8,272,930 | - | - | - | - | 8,272,930 | - | 8,272,930 | ||
| Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | - | 21,718 | (21,718) | - | - | - | - | - | ||
| Effect of ECL on debt instruments measured at fair value through OCI | - | - | - | - | - | - | - | 623,199 | - | - | - | - | 623,199 | - | 623,199 | ||
| Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | - | 804,345 | - | 804,345 | - | 804,345 | ||
| Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | - | 883,684 | 883,684 | - | 883,684 | ||
| Ending balance | 30,431,580 | 6,208,674 | 62,422,792 | 1,550,906 | - | (670,972) | 22,818 | (8,342,786) | 36,948 | 43,924,408 | 1,667,230 | 1,032,037 | 138,283,635 | 122,661 | 138,406,296 | ||
| Sep. 30, 2025 | Issued and paid capital | Legal reserve | General reserve | General risk reserve | Special reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders' Equity | Non-Controlling Interest | Total | ||
| 30,431,580 | 6,208,674 | 62,422,792 | 1,550,906 | - | (670,972) | 22,818 | (7,145,283) | 17,924 | 56,791,883 | 1,868,235 | 1,137,720 | 152,636,277 | 183,044 | 152,819,321 | |||
| Capital increase | 276,930 | - | - | - | - | - | - | - | - | - | - | - | 276,930 | - | 276,930 | ||
| Transferred to reserves | - | 2,771,284 | 19,758,610 | - | - | - | 2,246 | - | - | (21,744,828) | (787,312) | - | - | - | - | ||
| Dividends paid | - | - | - | - | - | - | - | - | - | (14,714,434) | - | - | (14,714,434) | (59,420) | (14,773,854) | ||
| Net profit for the period | - | - | - | - | - | - | - | - | - | 62,099,695 | - | - | 62,099,695 | 569 | 62,100,264 | ||
| Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | - | - | (110,995) | - | 110,995 | - | - | - | - | - | ||
| Transferred from net profit to special reserve | - | - | - | - | 13,145,012 | - | - | - | - | (13,145,012) | - | - | - | - | - | ||
| Transferred to general risk reserve | - | - | - | 26,186 | - | - | - | - | - | (26,186) | - | - | - | - | - | ||
| Net change on financial assets at fair value through OCI after tax | - | - | - | - | - | - | - | 7,192,292 | - | - | - | - | 7,192,292 | 113,897 | 7,306,189 | ||
| Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | - | (2,628) | 2,628 | - | - | - | - | - | ||
| Effect of ECL on debt instruments measured at fair value through OCI | - | - | - | - | - | - | - | (397,890) | - | - | - | - | (397,890) | - | (397,890) | ||
| Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | - | 990,324 | - | 990,324 | - | 990,324 | ||
| Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | - | (274,766) | (274,766) | - | (274,766) | ||
| Ending balance | 30,708,510 | 8,979,958 | 82,181,402 | 1,577,092 | 13,145,012 | (670,972) | 25,064 | (461,876) | 15,296 | 69,374,741 | 2,071,247 | 862,954 | 207,808,428 | 238,090 | 208,046,518 | ||
Recent news on Commercial International Bank Egypt CIB
See all newsEgypt's Commercial International Bank's Kenya unit aims to triple market share in two years
Brief: EGX Changes Launch Date For Futures Contracts On CIB And TMG Holding To June 21
Brief: EGX To Launch Derivatives For CIB & TMG By 18 June
Mideast Stocks: Most Gulf markets surge on US-Iran peace deal expectations
Mideast Stocks: Gulf bourses fall as US-Iran uncertainty keeps investors cautious